Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the changed medicines which were referred to the Minister of Health under the provisions of section 24 (5) of the act and are set out in the schedule hereto:
Schedule
Product: Sandoglobulin
Active Ingredient(s): Normal immunoglobulin 1g
Dosage Form: Powder for injection
NZ Sponsor: Novartis New Zealand Limited
Manufacturer(s): Swiss Red Cross Blood Transfusion Services, Central Laboratory, Berne, Switzerland
Product: Sandoglobulin
Active Ingredient(s): Normal immunoglobulin 3g
Dosage Form: Powder for injection
NZ Sponsor: Novartis New Zealand Limited
Manufacturer(s): Swiss Red Cross Blood Transfusion Services, Central Laboratory, Berne, Switzerland
Product: Sandoglobulin
Active Ingredient(s): Normal immunoglobulin 6g
Dosage Form: Powder for injection
NZ Sponsor: Novartis New Zealand Limited
Manufacturer(s): Swiss Red Cross Blood Transfusion Services, Central Laboratory, Berne, Switzerland
Dated this 12th day of January 2000.
G. R. BOYD, Chief Advisor, Safety and Regulation (pursuant to delegation given by the Minister of Health on the 20th day of February 1997).